Part D and dually eligible patients with mental illness: medication access problems and use of intensive services.

OBJECTIVE This study examined the occurrence of medication access problems and use of intensive mental health services after the transition in January 2006 from Medicaid drug coverage to Medicare Part D for persons dually eligible for Medicaid and Medicare benefits. METHODS Psychiatrists randomly selected from the American Medical Association's Physicians Masterfile reported on experiences of one systematically selected dually eligible patient (N=908) in the nine to 12 months after Part D implementation. Propensity score matching was used to compare use of psychiatric emergency department care and inpatient care between individuals who experienced a problem accessing a psychiatric medication after Part D and those who did not. RESULTS Approximately 44% of dually eligible patients were reported to have experienced a problem accessing medications. The likelihood of visiting an emergency department was significantly higher for those who experienced an access problem than for those who did not (mean odds ratio=1.75, mean p=.003). There was no difference in number of emergency department visits or hospitalizations for those who had at least one. CONCLUSIONS Many dually eligible patients had difficulty accessing psychiatric medications after implementation of Part D. These patients were significantly more likely to visit psychiatric emergency departments than patients who did not experience difficulties. These findings raise concerns about possible negative effects on quality of care. Additional study is needed to understand the full effects of Part D on outcomes and functioning as well as treatment costs for this population.

[1]  M. Rubio‐Stipec,et al.  First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients. , 2010, The Journal of clinical psychiatry.

[2]  S. Crystal,et al.  Medicaid prescription drug policies and medication access and continuity: findings from ten states. , 2009, Psychiatric services.

[3]  S. Zuvekas,et al.  Dual eligibles with mental disorders and Medicare part D: how are they faring? , 2009, Health affairs.

[4]  Hhs Centers for Medicare Medicare Services.  Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period. , 2009, Federal register.

[5]  Fang Zhang,et al.  Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. , 2008, Health affairs.

[6]  A. Rodday,et al.  Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. , 2007, Health affairs.

[7]  M. Rubio‐Stipec,et al.  Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit. , 2007, The American journal of psychiatry.

[8]  J. Newhouse,et al.  Coverage and prior authorization of psychotropic drugs under Medicare Part D. , 2007, Psychiatric services.

[9]  Nancy H. Covell,et al.  Effectiveness of switching antipsychotic medications. , 2006, The American journal of psychiatry.

[10]  J. Donohue.  Mental health in the Medicare Part D drug benefit: a new regulatory model? , 2006, Health affairs.

[11]  R. D'Agostino.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. , 2005, Statistics in medicine.

[12]  P. Weiden,et al.  Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. , 2004, Psychiatric services.

[13]  A. Pickles,et al.  The evolution of insight, paranoia and depression during early schizophrenia , 2004, Psychological Medicine.

[14]  R. Scheffler,et al.  Comparison of psychiatrists and psychologists in clinical practice. , 2002, Psychiatric services.

[15]  B. Svarstad,et al.  Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. , 2001, Psychiatric services.

[16]  H. Wagner,et al.  Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness , 2000, British Journal of Psychiatry.

[17]  J. Lieberman,et al.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. , 1999, Archives of general psychiatry.

[18]  P. Shrout,et al.  Symptom Profiles and Homelessness in Schizophrenia , 1994, The Journal of nervous and mental disease.

[19]  J. Hoadley,et al.  MEDICARE PART D 2009 DATA SPOTLIGHT: LOW-INCOME SUBSIDY PLAN AVAILABILITY MEDICARE PART D 2009 DATA SPOTLIGHT: LOW-INCOME SUBSIDY PLAN AVAILABILITY , 2009 .

[20]  D M Steinwachs,et al.  Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. , 1998, Schizophrenia bulletin.